PMI Science recently published the views of public health agencies as they relate to the harm and risk-reduced characteristics of heated tobacco products.
NEW YORK CITY — Tobacco giant Philip Morris International published on its research and development website a rundown document showing the views of several public health agencies as they related to heated tobacco devices and their risk-reduced properties.
“Health authorities around the world have begun to examine the evidence showing the potential role of smoke-free products in their harm reduction strategies if they have one,” indicates a reference article on the study published on PMI Science’s website on July 13.
Here are some of the positions on heated tobacco products some governments maintain:
United States of America and the Food and Drug Administration (FDA): PMI referred to a press release from the FDA that announced the authorization of the company’s IQOS system as a modified risk tobacco product. FDA notes: “The agency determined the company demonstrated that because the IQOS Tobacco Heating System heats tobacco and does not burn it, it significantly reduces the production of harmful and potentially harmful chemicals compared to cigarette smoke.”
United Kingdom and Public Health England: PMI cites the several evidence reviews that Public Health England (PHE) conducts on alternative nicotine products. PHE notes: “The available evidence suggests that heated tobacco products may be considerably less harmful than tobacco cigarettes and more harmful than e-cigarettes.”
Japan and the Department of Environmental Health/Japanese National Institute of Public Health: PMI cites an evidence review documenting the overall harm relative to cigarettes compared to traditional products and the IQOS system. The department found that “the concentration levels of hazardous compounds in the mainstream smoke of IQOS are much lower than those in conventional combustion cigarettes.”
Germany and the Federal Institute for Risk Assessment/Ministry for Food and Agriculture: The institute, after studying the aerosols from an IQOS device, the reductions “lead to the relevant questions of putatively reduced health risks.”
Tobacco Reporter reported on the PMI Science study on policy and scientific positions initially. You can read their coverage and the full study at PMI Science.
While smoking prevalence remains high, with around 1.3 billion people using high-risk forms of tobacco, over 80% of these live in LMICs.
Titled, “10 reasons why blanket bans of e-cigarettes and HTPs in low- and middle-income countries (LMICs) are not fit for purpose,” the INNCO (International Network of Nicotine Consumer Organisations) report points out that while smoking prevalence remains high, with around 1.3 billion people using high-risk forms of tobacco, over 80% of these live in LMICs.
The document was released in response to a position statement by the International Union Against Tuberculosis and Lung Disease (The Union), a Bloomberg partner for ‘The Initiative to reduce tobacco use’. In this statement The Union called for a blanket ban on all electronic nicotine delivery systems (ENDS) and heated tobacco products (HTPs) in LMICs.
The objective of the INNCO report “is to spark conversation about the right to reduce harm as a human rights issue and to highlight the inherent injustice associated with denying people access to safer alternatives simply because of where they live.”
The Bloomberg foreign funding issue
The INNCO is among over 35 national consumer organizations who recently voiced their concern about the foreign funding received by the Philippine Food and Drug Administration (FDA), and the negative influence it may have on local tobacco harm reduction efforts.
Recently appointed INNCO President Samrat Chowdhery, spoke of the influence exerted by non-government organizations backed by the Bloomberg Initiative, on regulators. “There is also an element of corruption aided by the Bloomberg NGOs, who are co-opting tobacco policy through the sheer force of money. The legislators in Philippines recently questioned the conflict of interest in their FDA receiving funds from these NGOs while pushing anti-vaping policy,” he said during the recent virtual presentation of “Burning Issues: The Global State of Tobacco Harm Reduction (GSTHR) 2020” published by UK public health agency Knowledge Action Change (KAC).
Japan Tobacco is expected to launch its next-generation heated tobacco product in August of 2021.
TOKYO — In a press release, Japan Tobacco Inc. (JT) announced that it would officially launch Ploom X, its proprietary next-generation heated tobacco product, on August 17, 2021. After the expected release, Ploom X will be sold across Japan in convenience stores and select tobacco retail locations throughout the country. A pre-launch sale will also be launched on July 26, 2021, at Japan Tobacco’s online e-commerce website.
Ploom X, according to the company, was developed in collaboration with Japan Tobacco in Tokyo, and Japan Tobacco International, based in Geneva, Switzerland. This means that a potential product release is expected to occur on the international stage in markets that feature a degree of high-end popularity for heated tobacco products and HnB devices.
“Ploom X is the first global device developed by JT and JTI, bringing together all our global resources to offer the best user experience of our time,” said Daniel Torras, a senior vice president for reduced-risk products. “We are delighted to be able to offer this new innovative product to adult consumers in Japan, the world’s leading heated tobacco market and where product standards and quality are of the highest importance.”
“Listening to consumers globally, we have created a proposition that is aligned with today’s lifestyles and choices,” Torras added. “This includes a more authentic tobacco taste, new connectivity possibilities and several options to personalize the device to everyday needs. Ploom X will make the user experience more pleasurable and unique than ever before. With Ploom X, we are continuing to build on our growing presence in the fast-moving heated tobacco sticks category and respond to the increasingly demanding needs of adult consumers around the world.”
Japan is the world’s largest market for heated tobacco products. JT competes aggressively with other tobacco companies across the world to control the heated tobacco market.
The companies that do so include Philip Morris International (PMI) with its IQOS system; British American Tobacco and its Glo device; and Imperial Brands and its Pulze device. Altria Group latches on to PMI to sell the IQOS system in the United States of America.
The UK is very progressive in terms of endorsing the use of e-cigarettes for smoking cessation. To this effect, noting this comparative under use of e-cigarettes is important especially as ethnic minority groups in England appear to be at a higher risk of smoking-related diseases. An article on EurekAlert points out that a NICE guidance says that reducing smoking prevalence could reduce those health inequalities more than any other measure.
People in lower socioeconomic groups are more likely to smoke
Similarly, a recent study currently being reviewed by the University of Helsinki, found that in Finland, citizens belonging to lower socioeconomic groups are more likely to smoke than their peers in higher groups.
“We know smoking has directly adverse effects on human health. Based on the study, it can be said that if this trend continues, so too will the growth of health inequalities,” said Otto Ruokolainen, an expert at the National Institute for Health and Welfare (THL) and author of the Finnish study. The research also indicated that raising tobacco prices is a motivating factor for smokers to quit.
The study analysed population data covering a 40-year period from 1978 to 2017, and the number of respondents across the different surveys varied from fewer than 1,000 to around 400,000.
The research highlighted the fact that people in lower socioeconomic groups tend to be less likely to quit smoking than their peers in higher groups. Ruokolainen said that government policies need to address this. “There should be better support for smokers and a particular focus on supporting people in lower socioeconomic groups in order to reduce their smoking to the same level as those in higher groups,” he said.
Similar patterns amongst indigenous Australians
A paper by researchers from the Australian National University, indicated similar patterns. The research team compiled data from 1,388 Aboriginal people from New South Wales, who participated in the 45 and UP study, a longitudinal study run by the Sax Institute of 267,153 people aged 45 and older, randomly selected from the NSW population.
Half of all deaths amongst Aboriginal and Torres Strait Islander people over the age of 45, were tragically caused by smoking-related illnesses, equating to about 10,000 premature preventable deaths, reported the study. This means that smokers in these groups, are dying approximately 10 years earlier than non-smokers.
The WHO is at it again as a new report slams vaping as harmful and the gateway to kids becoming hooked on smoking.
The report is filled with the usual inaccuracies and downright lies about vaping, and calls for much tighter controls on all things vape in countries where e-cigarettes are not already banned.
As you can imagine, the lies perpetuated by the World Health Organization report has angered vape advocates from across the globe and we’ll look at the reactions in a moment.
Funded by anti-vaping czar little Mike ‘Moneybags‘ Bloomberg, the report is titled: WHO reports progress in the fight against tobacco epidemic – I won’t give them our link juice so please feel free to Google it.
In a nutshell, the so called ‘guardians‘ of world health say:
The aerosols from e-cigarettes contain toxic substances that can cause:
Anatomical heart cardiovascular diseases
Lungs lung disorders
Brain damage to children’s brain development
It’s all deeply flawed science – or BS as I call it – and each of those key points has been disproven time and time again.
However, as the WHO gears up for the COP9 event in November, where it plans to call for a global ban on vaping, this report shows without doubt the unelected mandarins have a very different agenda than saving smokers lives.
The WHO says:
For the first time, the 2021 report presents new data on electronic nicotine delivery systems, such as ‘e-cigarettes’.
These products are often marketed to children and adolescents by the tobacco and related industries that manufacture them, using thousands of appealing flavours and misleading claims about the products..
WHO is concerned that children who use these products are up to three times more likely to use tobacco products in the future.
The Organization recommends governments to implement regulations to stop non-smokers from starting to use them, to prevent renormalization of smoking in the community, and to protect future generations..
The ‘Organization…‘ sounds very mafia lol…
However, it’s an interesting use of words at the end that got my nose twitching.
The WHO hasn’t gone ‘all in‘ calling for a total ban – instead it’s urging governments in countries where vaping isn’t banned, to bring in tough legislation to stop none smokers and kids from taking the habit up.
Now to me that’s curious…
For a start the number of never smokers that vape is so low it can barely be recorded.
Add to that the number of kids vaping is ever decreasing – especially here in the UK as I reported in Sunday’s Vape News.
And hey, here’s a thought, maybe lit tobacco sales have fallen because despite the media and money driven myths, people are thinking for themselves, weighing up the evidence and making a choice to opt for safer nicotine delivery systems.
Don’t forget, nicotine isn’t carcinogenic – it’s the tar and other shite in lit tobacco smoke that kills over 8 million smokers each year…
And of course, nicotine is VERY similar to caffeine and you don’t see Parents Against Starbucks groups popping up anywhere…but I digress.
Although I have to say, if patches and gums are classed as good nicotine – what’s the bloody difference?
WHO Slams Vaping As Harmful Leaving Smokers and Vaper Left To Die
Dr Rüdiger Krech, Director of the Health Promotion Department at WHO, continued the attack on all things vape saying:
These products are hugely diverse and are evolving rapidly.
Some are modifiable by the user so that nicotine concentration and risk levels are difficult to regulate.
Others are marketed as ‘nicotine-free’ but, when tested, are often found to contain the addictive ingredient.
Distinguishing the nicotine-containing products from the non-nicotine, or even from some tobacco-containing products, can be almost impossible.
This is just one way the industry subverts and undermines tobacco control measures.
*sighs and bangs head on desk*
Just imagine if vaping was banned globally and the 50 or so million of us had to turn to the black market and all the dangers that would bring.
Even worse, imagine the numbers of vapers returning to smoking and to put it crudely, smoked themselves to death.
Doesn’t bare thinking about, but the WHO obviously has and couldn’t give a shit as long as benefactors like Bloomberg continue pouring millions of dollars into the WHO’s trough.
Someone has to pay for all those first class 5 star junkets they seem to love going on…
WHO director-general Dr Tedros Adhanom Ghebreyesus – who’s not a medical doctor lol, said:
Electronic nicotine delivery systems are harmful, and must be better regulated.
Where they are not banned, governments should adopt appropriate policies to protect their populations from the harms of electronic nicotine delivery systems, and to prevent their uptake by children, adolescents and other vulnerable groups.
No one has EVER said vaping is not without some risk – but weigh the evidence – study the data from real world cases – and learned medical bodies with global respect say it’s at least 95% safer than smoking
And for FFS – you can’t get more ‘vulnerable‘ to death and life changing illnesses than by smoking…
Pro Vaping Advocates Respond To Damming Report
As I said earlier, pro-vaping advocates and have been quick to respond to yet another WHO slams vaping as harmful ‘report’.
Those condemning yet another pile of crap from the WHO includes real medical experts, the vaping industry and advocates.
Professor John Britton, emeritus Professor of Epidemiology at University of Nottingham, said:
This report demonstrates that, sadly, the WHO still doesn’t understand the fundamental difference between addiction to tobacco smoking, which kills millions of people every year, and addiction to nicotine, which doesn’t.
The WHO is also evidently still content with the hypocrisy of adopting a position which recommends the use of medicinal nicotine products to treat addiction to smoking, but advocates prohibition of consumer nicotine products which do the same thing, but better.
The WHO is right that non-smokers, especially children, should be discouraged from using any nicotine product.
But for the more than one billion tobacco smokers in the world, electronic nicotine delivery systems are part of the solution, not the problem.
As always, the professor is the voice of reason and calm in a swirling sea of BS…
The UK Vaping Industry Association condemns the WHO report, and director general John Dunne, as he always does, shot straight from the hip:
The WHO has a long-standing anti-vaping stance and this latest attack on a sector that is literally saving millions of lives worldwide flies in the face of scientific evidence, common sense and harm reduction.
The fundamental difference between the UK and the WHO is that the UK has taken a science and evidence-led approach towards vaping.
And the evidence clearly shows the enormous role vaping products play in helping smokers to quit and stay quit.
The WHO, on the other hand, has chosen to do the prohibition route, effectively calling for a ‘ban on everything’ except combustible tobacco products – does that sound like an organisation trying to reduce smoking?
We know we are on the right side of the argument, prioritising as we do, health protection and harm reduction.
The WHO, however, seems hell-bent on preventing smokers’ access to the one quit method proven to not only help smokers quit cigarettes, but to do so long term.
Michael Landl, Director of the World Vapers’ Alliance (WVA), said:
Besides being riddled with biased anti-vaping scaremongering and false claims, the entire direction of travel set out in the latest WHO report is nonsensical.
Rather than focus on the all-important goal of beating smoking, the WHO is turning its guns on vaping, the most powerful smoking cessation tool on the planet.
They clearly find it more important to fall into line with the narrow-minded ‘quit or die’ approach trumpeted by the WHO’s billionaire sponsors, like Mike Bloomberg.
The reality is that if the world follows the WHO’s lead, fewer smokers will quit and more will die as a consequence.
Wise words indeed.
David Jones MP, who sits on the UK’s All Party Parliamentary Group for Smoking and Health, was equally perplexed at the WHO report slamming vaping as harmful saying:
Our advice remains that people who smoke are better to switch completely to vaping.
That opinion, however, is not shared by the WHO, which has long pursued an almost pathological campaign against e-cigarettes.
The UK Government’s health promotion body, Public Health England (PHE), says that: ‘Vaping is not risk free but is far less harmful than smoking’.
Using reduced-risk products such as vapes or heat-not-burn devices is demonstrably safer than smoking cigarettes.
There are no serious debates to be had here.
PHE is very clear about it: such products are around 95 percent safer than combustible tobacco.
The WHO is simply wrong.
The UK should reject its calls and continue to develop its own science-based guidelines, helping people quit the habit that claims so many lives.
Isn’t it refreshing to have UK politicians backing vaping!
Yet again the WHO slams vaping as harmful in a report that belongs in the scientific and health stone age.
They really are better suited to carving their so called ‘reports and studies‘ on stone tablets whilst howling at the moon – that’s how far away from modern science these dangerous buffoons are.
Tobacco harm reduction has long since left the cave and actually dumped the fire and swapped it for safer none combustibles.
I’ve got no idea how long it will take for the WHO to catch up with the real facts and science around all things vape – if they ever will.
They are quite simply led by money and not the world’s health.
Trust me, if Bloomberg and his kind were pro-vaping so would the WHO – it’s that blatantly obvious it hurts my old brain.
Sadly and whilst these blind to science benefactors continue to fill the trough, the WHO won’t be doing a 180 anytime soon.
And that, I’m afraid, will simply sentence billions of smokers and possibly vapers, to a slow agonizing death or serious illness.
As I’ve said before, shame on them and they really do have blood on their collective greedy money grabbing hands.
Absolute bastards…all of them.
Get Involved and Help Fight the WHO
Advocacy groups are gearing up for the mother of all vaping battles as the WHO demands a global ban on vaping.
Sign up with advocacy groups – sign the petition and get your voices heard now before it’s too late:
The Chinese manufacturer hopes that with the worldwide presence that will come as a result of this collaboration, new possibilities will open up. The brand is aptly called GeekVape in a bid to appeal to people who are curious and believe in the power of change, which the vape business says, are two major traits of geeks. In line with these principles, Geekvape is seeking opportunities in sports.
The e-cig manufacturer believes that since PSG is a relatively young football club with a lot of potential, via the partnership the brand will continue to strengthen its position “as a game changer in the world of football backed by its proven track record of fearlessly exploring its potential for growth.” Geek Vape believes that being a combination of sports and competition, football is a sport that encourages a healthy competitive spirit and actions that push the envelope, all qualities that are aligned with the values and beliefs of Geekvape.
Geek Aid programs
In a press release about the partnership, Geekvape said that it is committed to being socially responsible and is therefore committed to the research and development of sustainable materials and public programs. The manufacturer also plans to launch a series of Geek Aid programs for the public welfare in partnership with PSG, the aim of which is “expanding the traits of geeks to include love and responsibility while also enhancing their emotional and spiritual maturity.”
In what is almost certainly a preview of policies that will be urged at the fall meeting of the World Health Organization’s Framework Convention on Tobacco Control (FCTC), the WHO has issued a report on “new and emerging” tobacco and nicotine product use that encourages countries to adopt harsh anti-vaping and anti-harm reduction positions.
There is literally nothing new in the report. It’s the usual set of complaints and lies about vaping, and a reupping of the evergreen list of excuses for the WHO’s own feeble anti-smoking progress. Worldwide tobacco control efforts would be going swimmingly, the WHO says, except for those darn tobacco and “related” companies’ attempts to reverse the progress by encouraging uptake of non-combustible nicotine products like vapes (which, as usual, are called ENDS).
Vaping products contain nicotine, they explain, which may affect adolescent brain development. They’re marketed in thousands of flavors, which “can increase the palatability of the product and help them be targeted specifically at children and young adults.”
“Eighty-four countries still have no bans or regulations to address ENDS, leaving them particularly vulnerable to the activities of the tobacco and related industries,” says the report. Adolescents who vape, according to the WHO, are “more than twice as likely to later use conventional cigarettes.” (That has certainly not borne out with real live teenagers in the United States, where school-age smoking has fallen dramatically as teen vaping increased, and high schoolers smoked more in the only U.S. city with a total vape ban.)
The report was funded by Bloomberg Philanthropies, the foundation started by American billionaire and former New York City mayor Michael Bloomberg. Not coincidentally, Bloomberg has been appointed the “WHO Global Ambassador for Noncommunicable Diseases and Injuries”—a largely honorary title granted in recognition of the money he spends on tobacco control and other health policy efforts.
Bloomberg Philanthropies has spent billions funding the spread of prohibitionist dogma in countries around the world. In low- and middle-income countries (LMICs), Bloomberg-funded groups like the Campaign for Tobacco-Free Kids and The Union have urged outright bans on e-cigarettes, claiming those countries are incapable of properly implementing reasonable regulations.
In theory, the WHO and FCTC exist to create and promote health strategies demanded by member states. In reality, WHO tobacco policy goals and plans come from the top down. Bloomberg-sponsored Tobacco-Free Kids and its allies essentially run the WHO’s tobacco control operations as a subsidiary. It is those groups that will plot the recommendations the FCTC will present to member countries at November’s ninth Conference of the Parties (COP9) in the Netherlands.
But the WHO isn’t budging. “Nicotine is highly addictive. Electronic nicotine delivery systems are harmful, and must be better regulated,” said WHO Director-General Tedros Adhanom Ghebreyesus in a statement today.
Worldwide, smoking hasn’t declined since the launch of the FCTC nearly two decades ago. Indeed, the number of people who currently smoke (1.1 billion), and the number who die annually from smoking (eight million), has increased in that time.
It is in countries where low-risk nicotine products like vapes and snus are allowed that smoking rates have dropped the farthest and fastest. Only if you convince yourself that non-combustible nicotine products pose the same risks as cigarettes can vaping be considered the danger the WHO and its patron Bloomberg say it is.
“This report demonstrates that, sadly, the WHO still doesn’t understand the fundamental difference between addiction to tobacco smoking, which kills millions of people every year, and addiction to nicotine, which doesn’t,” said University of Nottingham Emeritus Professor of Epidemiology John Britton, who chaired the Royal College of Physicians’ Tobacco Advisory Group that produced that group’s landmark 2016 report on e-cigarettes.
“The WHO is also evidently still content with the hypocrisy of adopting a position which recommends the use of medicinal nicotine products to treat addiction to smoking, but advocates prohibition of consumer nicotine products which do the same thing, but better.”
Tobacco giant Altria Group finalized an agreement to sell its wine enterprise for $1.2 billion.
RICHMOND — Earlier this month, Altria announced that it will be selling off its entire wine business, Ste. Michelle Wine Estates, to private equity firm Sycamore Partners for a whopping $1.2 billion. This decision comes as the American tobacco giant intends to move away from the manufacture and sale of cigarettes in an attempt to adopt smoking alternatives, including electronic cigarettes, oral products, and cannabis-based products.
According to both companies, Sycamore Partners is a private equity firm working in the food and retail distribution segments.
“We believe the Transaction is an important step in Altria’s value creation for shareholders and allows our management team greater focus on the pursuit of our Vision to responsibly transition adult smokers to a non-combustible future,” said Billy Gifford, Altria Group’s CEO, in a press release on July 9, 2021. “Ste. Michelle and its talented employees have built an outstanding portfolio of premium wine brands, and we wish them future success.”
“The Ste. Michelle leadership team and I look forward to working with the team at Sycamore Partners and believe we are well-positioned to drive the next phase of our growth,” said David Dearie, Ste. Michelle’s president and CEO said in the same release.
Ste. Michelle sells wines from estates in Washington state, Napa Valley in California, and other parts of the United States’ various wine-growing regions. Altria took control of Ste. Michelle when it bought a smokeless tobacco company for $10.4 billion in 2008.
Reuters reported at the beginning of July of 2021 that the deal will close in the second half of this fiscal year.
Unfortunately, Altria has fumbled in investments in the past few years.
Outside of its storied ownership of Ste. Michelle, Altria Group has likely lost more money on its nearly $13 billion investment in former e-cigarette unicorn Juul Labs.
Tobacco firm Philip Morris International also announced around the same time its investment into British bio-pharma company Vectura Group plc.
Finally, some good news for the world of vaping, with the long-awaited Vapitaly 2021 event going ahead later this year!
Vapitaly 2021, held at the Fiera Roma Exhibition Center in Rome, will open its doors between Saturday October 2 and Sunday October 3, bringing together both the e-cig sector and the general public.
Particular attention will be paid to the safety of all participants, with nothing being left to chance.
The event will comply with national and regional COVID regulations, as well as the Exhibitions fairgrounds’ safety protocols, to allow the varied world of vaping to physically come together.
For over a year, the industry has been waiting to meet, share business experiences and build the human relationships that have been lacking so much in this time characterized by social distance.
To avoid the risk of crowding, the organizers have already planned for the use of space both internally and externally, as well as the possibility of limited admissions and limitations on tastings as required by law.
Thanks to careful planning, all participants will be able to live the unique experience of Vapitaly in complete safety, view the new products presented by national and international exhibitors, attend conferences and meet major stakeholders.
Exhibition spaces for Vapitaly 2021 are now available for purchase and we are inviting vaping companies to secure their place at Italy’s first physical vaping event after the lockdown.
Vapitaly allows you to witness a crucial moment in the restart of the industry and take part in an event that defines the strategies and trends of the entire market.
Manufacturers, retailers and importers will be reunited in the 11,000 sqm Hall One of the Fiera Roma Exhibition center, as well as outside areas and a dedicated B2B meeting space.
If you are interested in exhibiting at Vapitaly 2021 Rome, get in touch with the team either through email – [email protected] – or register through the Exhibitors portal which is accessible here.
Visitor registration will open in August; Remember to check Vapitaly’s website and subscribe to Vapitaly’s social media channels so you don’t miss any updates!
Several public health and tobacco control groups are upset that Philip Morris International would even consider purchasing a pharmaceutical maker that develops inhaled treatments for respiratory diseases, including the COVID-19 infection.
NEW YORK CITY — Philip Morris International (PMI) announced recently that it would pursue purchasing a company specializing in the development of inhaled pharmaceutical treatments for respiratory diseases based in the United Kingdom.
The company, Vectura Group plc (based in Chippenham, Wiltshire, in England), agreed to the acquisition, which is valued at between $1 billion and $1.5 billion. PMI announced the intent to purchase Vectura in a press release indicating that it’s a part of its so-called Beyond Nicotine strategy and its move away from combustible cigarettes.
“The acquisition of Vectura, following the recently announced agreement to acquire Fertin Pharma, will position us to accelerate this journey by expanding our capabilities in innovative inhaled and oral product formulations in order to deliver long-term growth and returns,” said Jacek Olczak, PMI’s chief executive officer, in the mentioned press release.
For reference, Vaping Postreported on the acquisition of Fertin Pharma. Fertin develops pharmaceutical and nutraceutical products based on proprietary “oral and intra-oral delivery systems.” Fertin develops pills, lozenges, capsules, powders, and pouches.
He added: “The market for inhaled therapeutics is large and growing rapidly, with significant potential for expansion into new application areas. PMI has the commitment to science and the financial resources to empower Vectura’s skilled team to execute on an ambitious long-term vision. Together, PMI and Vectura can lead this global category, bringing benefits to patients, to consumers, to public health, and to society-at-large.”
Groups like the American Lung Association and the American Thoracic Society are concerned that the acquisition will undo years of work at Vectura Group. American Lung Association President and CEO Harold Wimmer and American Thoracic Society President Lynn Schnapp jointly released this statement about PMI’s attempt to purchase Vectura:
“The announcement that Philip Morris International (PMI) wants to acquire an inhaled medicine company is the latest reprehensible choice from a company that has profited from addicting users to its deadly products,” both said. “We are deeply concerned that PMI will use the inhalation services technologies developed by Vectura to make their tobacco products more addictive. We are also deeply troubled that this company could further profit from the disease their products have caused by now selling therapies to the same people who were sickened by smoking PMI cigarettes.”
“The American Lung Association and American Thoracic Society are disappointed that the board of Vectura, a maker of essential medical products, has approved this sale. We urge the shareholders of Vectura to reject the proposed sale. Failing share holder action, we urge the British government to use its oversight authority to intervene and stop the sale.”
Amid the outbreak of controversy, members of Parliament are likely to scrutinize the acquisition between PMI and Vectura. London Timesreports that politicians in Parliament, including shadow secretaries dealing with business and biotechnology industry regulations, will further investigate the intentions behind the proposed buyout.